Shattuck Labs Will Present Data at UEG Week 2026

The biotech firm will share new research in Barcelona this October.

Updated on Oct. 13, 2026 in Biotech

Isometric editorial illustration showing a glass vial with a crystalline structure, representing advanced medical research and biotech findings.
Shattuck Labs is set to present new research on SL-846 and immune complexes at the United European Gastroenterology Week in Barcelona this October. AI Illustration. Upload story photo >

Shattuck Labs will present two research posters at the United European Gastroenterology Week 2026, scheduled to take place from October 17 to October 20, 2026, in Barcelona, Spain.

Why it matters

These presentations provide a platform for the company to share ongoing research findings regarding specific biological developments and immune complexes with the broader medical community.

Shattuck Labs has confirmed two scheduled presentations at the congress, including a moderated session on SL-846 and an ePoster presentation on TL1A immune complexes.

The players

Shattuck Labs

A biotechnology company with offices in Austin, Texas and Durham, North Carolina that focuses on developing new therapeutic proteins.

Mahmud Hussain

A presenter who will share findings regarding the development and characterization of SL-846 at the congress.

Suresh de Silva

A presenter who will lead an ePoster session regarding the production of TL1A in immune complexes.

The details

The presentations cover the characterization of SL-846 and the mechanics of soluble TL1A/Anti-TL1A immune complexes. Researchers will share these findings with international peers in Barcelona, with materials made available online after the congress concludes.

Timeline

  1. October 17-20, 2026: United European Gastroenterology Week takes place in Barcelona.

  2. October 19, 2026: The moderated poster presentation on SL-846 occurs.

The Big Picture

Participation in United European Gastroenterology Week places these research findings within the established global cycle of professional medical dissemination. This trajectory shifts the focus from internal laboratory development to peer-reviewed public disclosure and potential clinical validation.

These presentations represent milestones in research that may eventually influence future treatment standards in gastroenterology. Stakeholders and interested parties can track these developments for potential long-term impacts on patient care.

The takeaway

These upcoming presentations highlight the role of international scientific congresses in advancing specialized research. Interested parties should monitor formal updates following the event to understand the broader implications for medical technology.

What happens next

Posters will be available for public viewing on the company website after the conclusion of the event on October 20, 2026.

Further reading

For more information on the latest innovations, visit our Biotech section.

More information

View the complete details on the Company investor relations website.